BioCentury
ARTICLE | Clinical News

Lifitegrast regulatory update

April 13, 2015 7:00 AM UTC

FDA accepted and granted Priority Review to an NDA from Shire for lifitegrast to treat signs and symptoms of dry eye disease in adults. The PDUFA date is Oct. 25. Shire gained lifitegrast -- an eye dr...